Examination of the degree of HRGβ1 immunostaining in all patients identified no statistically significant correlations between HRGβ1 expression and the tumour grade, menopausal, nuclear oestrogen receptor, cytoplasmic TGFα, membrane erbB2 and membrane erbB3 status values. The gene discussed is TGFA; the disease is neoplasm.